VBI Vaccines, Inc. - Ordinary Shares (VBIV) Social Stream
VBI VACCINES INC (VBIV) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VBIV.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-12-01 | 3 | $9 | $8 | $8.5 | $0.6 | 1316.67% |
2022-03-07 | 3 | $9 | $6 | $7.666 | $0.6 | 1177.67% |
2022-05-11 | 2 | $8 | $6 | $6.666 | $0.6 | 1011% |
2022-08-08 | 3 | $8 | $6 | $6.666 | $0.6 | 1011% |
2022-08-09 | 3 | $7 | $5 | $6 | $0.6 | 900% |
2022-11-11 | 2 | $6 | $2 | $4 | $0.6 | 566.67% |
The Trend in the Analyst Price Target
VBIV's average price target has moved down $1.67 over the prior 27 weeks.
VBIV reports an average of 552.16% for its upside potential over the past 36 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-03-07 | 3 | 9 | 6 | 7.666 | 1.330 | 476.39% |
2022-03-14 | 3 | 8 | 6 | 6.666 | 1.270 | 424.88% |
2022-08-08 | 3 | 8 | 6 | 6.666 | 1.040 | 540.96% |
2022-11-11 | 2 | 7 | 2 | 5.000 | 0.597 | 737.52% |
2022-11-11 | 3 | 7 | 2 | 5.000 | 0.597 | 737.52% |
VBIV Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1.5 | 1 | 1 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 35 weeks, VBIV's average broker recommendation rating worsened by 0.33.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, VBI VACCINES INC's upside potential (average analyst target price relative to current price) is higher than 776.6% of them.
- VBI VACCINES INC's average analyst price target is higher than 46.36% of all US stocks.
- In terms of how VBI VACCINES INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 59.92% of that group.
- In the context of Pharmaceutical Products stocks, VBI VACCINES INC's variance in analysts' estimates is lower than -143.85% of them.
Stocks similar to VBI VACCINES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ATNF, ATNX, and GTHX.
View All Top Stocks by Price Target
Make investment decisions regarding VBIV using the data that counts. Try POWR Ratings for free.